Mediclinic, the primary care group in the Czech Republic, was quietly sold to management by Penta Investments, the big Slovak private equity house, at the start of 2014. We look at the main players in the Czech primary care sector.
Minds & Machines: healthcare and the industrial internet - Jean-Michel will explain what the industrial internet means to healthcare and how this will help boost operator productivity. Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
Martin gives a detailed overview of transactions and volumes in Europe over the last year, focusing specifically on valuations. With stock market multiples at near record levels, he asks whether we are we about to see the return of a bull market in mergers and acquisitions. Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
Joe has 17 years experience as CFO of Medicover, the only Pan-East European provider of comprehensive medical services from insurance to hospitals, ambulatory centres and diagnostics. Medicover is active across Poland, Germany, Romania, Ukraine, Turkey, Belarus, the Balkans and other ex-Soviet republics. Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
How to improve care and drive productivity in health providers. What works today? What will work in five years time? Presented at the Healthcare Europa Annual Conference 2014, The Return of the Bull Market.
Orpea, the big quoted French nursing home group with operations in Belgium, Spain and Italy, has pipped local contenders to buy Senevita, one of the top three Swiss nursing home chains from Austrian operator Senecura. The acquisition takes Orpea into a fast-growing, but low margin sector. We look at the Swiss market, give you the price and multiple on the deal, talk to Orpea about its plans and examine what Senecura plans to do with the money.
Who would ever feel sorry for big reagent manufacturers - Abbott, Roche and Siemens? Well, from what we hear, the big lab groups really are squeezing them dry.
The Proton Therapy Center (PTC) in Prague, one of the very few private proton centres in Europe, is the source of a dispute between Erste Bank, which lent it CZK 4.2bn (€153m) and VZP, the largest Czech insurer. We look at what is going on, and at the business model behind it.
Alpha Medical, part of the East European lab chain owned by private equity house Mid Europa, has acquired seven labs from Euromedic in the Czech Republic. The move will almost doubles Alpha's sales. We talk to Peter Lednicky, CEO of Alpha Medical, about the deal, and look at the wider East European lab market.
How profitable are the Czech Republic's public and private hospitals? How indebted are they? A new report sheds some light on the situation, showing that some private hospitals are running 16% EBITDA margins. Given that the next general election could lead to a new wave of functional privatisations, this could open up a big - and, apparently, profitable - new sector.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.